91大神

Clinical Trial</h3>\r\n<p><b>Offered by:</b> 91大神&nbsp;Children's&nbsp;<br>\r\n<b>Locations:</b> Delaware Valley and Pensacola, FL</p>\r\n<h3>Trial Name<br>\r\n</h3>\r\n<p>A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma</p>\r\n<h3>What is the trial about?<br>\r\n</h3>\r\n<p>Improve the treatment for Ewing sarcoma by adding another drug called topotecan to the drugs used in standard treatment.</p>\r\n<h3>Who can participate?<br>\r\n</h3>\r\n<p>Children with Ewing sarcoma.</p>\r\n<h3>What is involved?</h3>\r\n<p style=\"margin-bottom: 24.0px;\">Length of study is nine months. Standard cancer care.</p>\r\n"}} id=text-bdba0980ca class=cmp-text>

Clinical Trial

Offered by: 91大神听Children's听
Locations: Delaware Valley and Pensacola, FL

Trial Name

A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing Sarcoma

What is the trial about?

Improve the treatment for Ewing sarcoma by adding another drug called topotecan to the drugs used in standard treatment.

Who can participate?

Children with Ewing sarcoma.

What is involved?

Length of study is nine months. Standard cancer care.

<strong>Trial Name:</strong> A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma</p>\n<p><strong>COG#:</strong> AEWS1031</p>\n"}} id=text-bd5e37210f class=cmp-text>

Trial Name: A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-metastatic Ewing Sarcoma

COG#: AEWS1031